2 false false false false false false false false false true false false false false false false No description of principal activity 2023-01-09 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 14578617 2023-01-09 2024-01-31 14578617 2024-01-31 14578617 bus:RegisteredOffice 2023-01-09 2024-01-31 14578617 bus:LeadAgentIfApplicable 2023-01-09 2024-01-31 14578617 bus:Director1 2023-01-09 2024-01-31 14578617 bus:Director2 2023-01-09 2024-01-31 14578617 core:WithinOneYear 2024-01-31 14578617 core:AfterOneYear 2024-01-31 14578617 bus:Micro-entities 2023-01-09 2024-01-31 14578617 bus:AuditExemptWithAccountantsReport 2023-01-09 2024-01-31 14578617 bus:FullAccounts 2023-01-09 2024-01-31 14578617 bus:SmallCompaniesRegimeForAccounts 2023-01-09 2024-01-31 14578617 bus:PrivateLimitedCompanyLtd 2023-01-09 2024-01-31
COMPANY REGISTRATION NUMBER: 14578617
Biovit Ltd
Filleted Unaudited Financial Statements
31 January 2024
Biovit Ltd
Financial Statements
Period from 9 January 2023 to 31 January 2024
CONTENTS
PAGE
Officers and professional advisers
1
Statement of financial position and the notes to the financial statements
2
Biovit Ltd
Officers and Professional Advisers
The board of directors
Mr K Wright (Appointed 9th January 2023)
Mr T Lavis (Appointed 14th December 2023)
Registered office
32 The Norton
Tenby
Wales
SA70 8AB
Accountants
James & Uzzell Ltd
Chartered Certified Accountants
Axis 15, Axis Court
Mallard Way
Riverside Business Park
Swansea
SA7 0AJ
Biovit Ltd
Statement of Financial Position
31 January 2024
Period from
9 Jan 23 to
31 Jan 24
£
Fixed assets
1,058
------
Current assets
131,270
Creditors: amounts falling due within one year
36,351
---------
NET CURRENT ASSETS
94,919
--------
TOTAL ASSETS LESS CURRENT LIABILITIES
95,977
Creditors: amounts falling due after more than one year
8,282
--------
87,695
--------
Capital and reserves
87,695
--------
NOTES TO THE FINANCIAL STATEMENTS
1. EMPLOYEE NUMBERS
The average number of persons employed by the company during the period amounted to 2 .
2. GOING CONCERN
The directors have considered the future trading position of the company and are confident that the going concern principle can be applied to the financial statements, with ongoing support from the directors and investors.
3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES
The amount owed by the directors at the year end is £383.
No interest has been incurred in relation to this balance.
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 19 September 2024 , and are signed on behalf of the board by:
Ky Peter Morgan Wright
Ky Peter Morgan Wright
Director
Company registration number: 14578617
Biovit Ltd is a private company limited by shares incorporated in England & Wales, United Kingdom. The address of the registered office is given in the company information on page 1 of these financial statements.